This section is not available in the published analysis.
Opus Genetics: Audience
Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company focused on developing innovative gene therapies for inherited retinal diseases. Their mission is to preserve vision by targeting genetic mutations that lead to vision loss.